Diagnostic Performance of a Receptor-Binding Radiopharmacokinetic Model
The aim of this study was to determine which measurement obtained from a radiopharmacokinetic model of a receptor-binding radiotracer provides the highest diagnostic performance for the detection of diffuse hepatocellular disease. Twenty-seven healthy subjects and 46 patients with diffuse hepatocell...
Saved in:
Published in: | The Journal of nuclear medicine (1978) Vol. 37; no. 1; pp. 160 - 164 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
Reston, VA
Soc Nuclear Med
01-01-1996
Society of Nuclear Medicine |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The aim of this study was to determine which measurement obtained from a radiopharmacokinetic model of a receptor-binding radiotracer provides the highest diagnostic performance for the detection of diffuse hepatocellular disease.
Twenty-seven healthy subjects and 46 patients with diffuse hepatocellular disease were studied with the receptor-binding radiopharmaceutical, 99mTc-galactosyl-neoglycoalbumin. A radiopharmacokinetic model was used to produce estimates of receptor concentration [R]o, the scaled forward-binding rate constant Kb, hepatic plasma volume, Vh, extrahepatic plasma volume, Ve and hepatic plasma flow, F. Receiver operating characteristic analysis of each model estimate was conducted.
Receptor concentration [R]o and the metrics [R]o/tbw and kb[R]o[R]o/tbw provided the best discrimination between healthy and diseased liver. The forward-binding rate constant kb and the metrics F/Ve and Vh/tbw provided no discrimination.
Based on simplicity and higher measurement precision, [R]o was selected as the most accurate index of hepatic function. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0161-5505 1535-5667 |